Annual CFO
-$4.12 M
+$5.43 M+56.83%
December 1, 2024
Summary
- As of March 9, 2025, BBLG annual cash flow from operations is -$4.12 million, with the most recent change of +$5.43 million (+56.83%) on December 1, 2024.
- During the last 3 years, BBLG annual CFO has fallen by -$2.90 million (-235.74%).
- BBLG annual CFO is now -866.25% below its all-time high of -$426.90 thousand, reached on December 31, 2020.
Performance
BBLG Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.35 M
-$781.30 K-136.54%
December 1, 2024
Summary
- As of March 9, 2025, BBLG quarterly cash flow from operations is -$1.35 million, with the most recent change of -$781.30 thousand (-136.54%) on December 1, 2024.
- Over the past year, BBLG quarterly CFO has dropped by -$781.30 thousand (-136.54%).
- BBLG quarterly CFO is now -1774.65% below its all-time high of -$72.20 thousand, reached on September 30, 2020.
Performance
BBLG Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$4.13 M
+$664.50 K+13.87%
December 1, 2024
Summary
- As of March 9, 2025, BBLG TTM cash flow from operations is -$4.13 million, with the most recent change of +$664.50 thousand (+13.87%) on December 1, 2024.
- Over the past year, BBLG TTM CFO has increased by +$664.50 thousand (+13.87%).
- BBLG TTM CFO is now -918.52% below its all-time high of -$405.00 thousand, reached on March 31, 2021.
Performance
BBLG TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BBLG Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.8% | -136.5% | +13.9% |
| 3 y3 years | -235.7% | +62.7% | +43.7% |
| 5 y5 years | -26.9% | +62.7% | +43.7% |
BBLG Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -235.7% | +56.8% | -624.2% | +62.7% | -235.7% | +56.8% |
| 5 y | 5-year | -866.3% | +56.8% | -1774.7% | +62.7% | -918.5% | +56.8% |
| alltime | all time | -866.3% | +56.8% | -1774.7% | +62.7% | -918.5% | +56.8% |
Bone Biologics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$4.12 M(-56.8%) | -$1.35 M(+136.5%) | -$4.13 M(-13.9%) |
| Sep 2024 | - | -$572.20 K(-36.1%) | -$4.79 M(-29.3%) |
| Jun 2024 | - | -$895.90 K(-31.3%) | -$6.77 M(-28.8%) |
| Mar 2024 | - | -$1.30 M(-35.4%) | -$9.51 M(-0.5%) |
| Dec 2023 | -$9.56 M(+167.9%) | -$2.02 M(-21.0%) | -$9.56 M(+0.7%) |
| Sep 2023 | - | -$2.56 M(-29.7%) | -$9.49 M(+29.5%) |
| Jun 2023 | - | -$3.63 M(+169.1%) | -$7.33 M(+80.7%) |
| Mar 2023 | - | -$1.35 M(-30.8%) | -$4.06 M(+13.7%) |
| Dec 2022 | -$3.57 M(+190.3%) | -$1.95 M(+393.5%) | -$3.57 M(+97.8%) |
| Sep 2022 | - | -$395.30 K(+9.8%) | -$1.80 M(+7.0%) |
| Jun 2022 | - | -$360.10 K(-58.2%) | -$1.69 M(-14.1%) |
| Mar 2022 | - | -$860.80 K(+360.6%) | -$1.96 M(+59.6%) |
| Dec 2021 | -$1.23 M(+187.8%) | -$186.90 K(-32.7%) | -$1.23 M(+5.2%) |
| Sep 2021 | - | -$277.80 K(-56.3%) | -$1.17 M(+21.4%) |
| Jun 2021 | - | -$636.00 K(+396.9%) | -$961.90 K(+137.5%) |
| Mar 2021 | - | -$128.00 K(+1.8%) | -$405.00 K(-5.1%) |
| Dec 2020 | -$426.90 K(-86.9%) | -$125.70 K(+74.1%) | -$426.90 K(-28.7%) |
| Sep 2020 | - | -$72.20 K(-8.7%) | -$598.90 K(-40.2%) |
| Jun 2020 | - | -$79.10 K(-47.2%) | -$1.00 M(-59.5%) |
| Mar 2020 | - | -$149.90 K(-49.6%) | -$2.47 M(-24.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$3.25 M(-20.8%) | -$297.70 K(-37.3%) | -$3.25 M(-24.3%) |
| Sep 2019 | - | -$474.50 K(-69.4%) | -$4.29 M(-15.8%) |
| Jun 2019 | - | -$1.55 M(+66.8%) | -$5.10 M(+21.0%) |
| Mar 2019 | - | -$929.00 K(-30.6%) | -$4.21 M(+2.7%) |
| Dec 2018 | -$4.10 M(+23.3%) | -$1.34 M(+4.6%) | -$4.10 M(+11.0%) |
| Sep 2018 | - | -$1.28 M(+92.0%) | -$3.70 M(+24.2%) |
| Jun 2018 | - | -$666.80 K(-18.6%) | -$2.98 M(-5.2%) |
| Mar 2018 | - | -$818.90 K(-12.1%) | -$3.14 M(-5.7%) |
| Dec 2017 | -$3.33 M(-54.6%) | -$931.70 K(+66.1%) | -$3.33 M(-9.2%) |
| Sep 2017 | - | -$561.00 K(-32.4%) | -$3.67 M(-20.5%) |
| Jun 2017 | - | -$829.30 K(-17.7%) | -$4.61 M(-20.6%) |
| Mar 2017 | - | -$1.01 M(-20.5%) | -$5.81 M(-20.7%) |
| Dec 2016 | -$7.33 M(+106.7%) | -$1.27 M(-15.8%) | -$7.33 M(+3.6%) |
| Sep 2016 | - | -$1.51 M(-25.7%) | -$7.07 M(+7.1%) |
| Jun 2016 | - | -$2.03 M(-19.8%) | -$6.61 M(+18.4%) |
| Mar 2016 | - | -$2.53 M(+150.0%) | -$5.58 M(+57.4%) |
| Dec 2015 | -$3.55 M(+28.7%) | -$1.01 M(-2.8%) | -$3.55 M(+39.9%) |
| Sep 2015 | - | -$1.04 M(+3.8%) | -$2.53 M(+69.6%) |
| Jun 2015 | - | -$1.00 M(+103.8%) | -$1.49 M(+203.8%) |
| Mar 2015 | - | -$491.80 K | -$491.80 K |
| Dec 2014 | -$2.76 M | - | - |
FAQ
- What is Bone Biologics annual cash flow from operations?
- What is the all time high annual CFO for Bone Biologics?
- What is Bone Biologics annual CFO year-on-year change?
- What is Bone Biologics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bone Biologics?
- What is Bone Biologics quarterly CFO year-on-year change?
- What is Bone Biologics TTM cash flow from operations?
- What is the all time high TTM CFO for Bone Biologics?
- What is Bone Biologics TTM CFO year-on-year change?
What is Bone Biologics annual cash flow from operations?
The current annual CFO of BBLG is -$4.12 M
What is the all time high annual CFO for Bone Biologics?
Bone Biologics all-time high annual cash flow from operations is -$426.90 K
What is Bone Biologics annual CFO year-on-year change?
Over the past year, BBLG annual cash flow from operations has changed by +$5.43 M (+56.83%)
What is Bone Biologics quarterly cash flow from operations?
The current quarterly CFO of BBLG is -$1.35 M
What is the all time high quarterly CFO for Bone Biologics?
Bone Biologics all-time high quarterly cash flow from operations is -$72.20 K
What is Bone Biologics quarterly CFO year-on-year change?
Over the past year, BBLG quarterly cash flow from operations has changed by -$781.30 K (-136.54%)
What is Bone Biologics TTM cash flow from operations?
The current TTM CFO of BBLG is -$4.13 M
What is the all time high TTM CFO for Bone Biologics?
Bone Biologics all-time high TTM cash flow from operations is -$405.00 K
What is Bone Biologics TTM CFO year-on-year change?
Over the past year, BBLG TTM cash flow from operations has changed by +$664.50 K (+13.87%)